333 related articles for article (PubMed ID: 7595079)
1. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway.
Karpe F; Hultin M
J Lipid Res; 1995 Jul; 36(7):1557-66. PubMed ID: 7595079
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
Bjorkegren J; Packard CJ; Hamsten A; Bedford D; Caslake M; Foster L; Shepherd J; Stewart P; Karpe F
J Lipid Res; 1996 Jan; 37(1):76-86. PubMed ID: 8820104
[TBL] [Abstract][Full Text] [Related]
3. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
Karpe F; Hellénius ML; Hamsten A
Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
[TBL] [Abstract][Full Text] [Related]
4. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
[TBL] [Abstract][Full Text] [Related]
5. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
Björkegren J; Karpe F; Milne RW; Hamsten A
J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
[TBL] [Abstract][Full Text] [Related]
6. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
7. Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase.
Xiang SQ; Cianflone K; Kalant D; Sniderman AD
J Lipid Res; 1999 Sep; 40(9):1655-63. PubMed ID: 10484612
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
Björnson E; Packard CJ; Adiels M; Andersson L; Matikainen N; Söderlund S; Kahri J; Hakkarainen A; Lundbom N; Lundbom J; Sihlbom C; Thorsell A; Zhou H; Taskinen MR; Borén J
J Intern Med; 2020 Oct; 288(4):422-438. PubMed ID: 31846520
[TBL] [Abstract][Full Text] [Related]
9. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients.
Cassader M; Gambino R; Musso G; Depetris N; Mecca F; Cavallo-Perin P; Pacini G; Rizzetto M; Pagano G
Lipids; 2001 Oct; 36(10):1117-24. PubMed ID: 11768156
[TBL] [Abstract][Full Text] [Related]
10. Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats.
Mamo JC; Hirano T; Sainsbury A; Fitzgerald AK; Redgrave TG
Biochim Biophys Acta; 1992 Oct; 1128(2-3):132-8. PubMed ID: 1420285
[TBL] [Abstract][Full Text] [Related]
11. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100.
Karpe F; Bell M; Björkegren J; Hamsten A
Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):199-207. PubMed ID: 7749826
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel method to determine very low density lipoprotein kinetics.
Al-Shayji IA; Gill JM; Cooney J; Siddiqui S; Caslake MJ
J Lipid Res; 2007 Sep; 48(9):2086-95. PubMed ID: 17548888
[TBL] [Abstract][Full Text] [Related]
14. Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
Taskinen MR; Matikainen N; Björnson E; Söderlund S; Inkeri J; Hakkarainen A; Parviainen H; Sihlbom C; Thorsell A; Andersson L; Adiels M; Packard CJ; Borén J
Diabetologia; 2023 Dec; 66(12):2307-2319. PubMed ID: 37775612
[TBL] [Abstract][Full Text] [Related]
15. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic glucagon administration on the metabolism of triacylglycerol-rich lipoproteins in rats fed a high sucrose diet.
Guettet C; Rostaqui N; Navarro N; Lecuyer B; Mathe D
J Nutr; 1991 Jan; 121(1):24-30. PubMed ID: 1992054
[TBL] [Abstract][Full Text] [Related]
17. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
18. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
Mero N; Malmström R; Steiner G; Taskinen MR; Syvänne M
Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648
[TBL] [Abstract][Full Text] [Related]
19. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.
Campos E; Nakajima K; Tanaka A; Havel RJ
J Lipid Res; 1992 Mar; 33(3):369-80. PubMed ID: 1569386
[TBL] [Abstract][Full Text] [Related]
20. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
Hazzard WR; Bierman EL
Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
